Tom MacLeod - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tom MacLeod

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Arthritis & Rheumatology (Hoboken, N.J.)|May 5, 2025

Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 AntagonismSami Giryes, Chi Wong, Charlie Bridgewood, et al.

Annals of the Rheumatic Diseases|September 26, 2025

Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritisPaula David, Tom Macleod, Ala Altaie, et al.

Rheumatology (Oxford, England)|December 9, 2025

Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitisKatya Meridor, Sook Yan Lee, Ilona Blee, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Arthritis & Rheumatology (Hoboken, N.J.)|May 5, 2025

Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 AntagonismSami Giryes, Chi Wong, Charlie Bridgewood, et al.

Annals of the Rheumatic Diseases|September 26, 2025

Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritisPaula David, Tom Macleod, Ala Altaie, et al.

Rheumatology (Oxford, England)|December 9, 2025

Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitisKatya Meridor, Sook Yan Lee, Ilona Blee, et al.

Pageof 3